1. Pink Sheet
  2. >>Archive

FDA Congressional Relations, Internal Structure May Change With Sharfstein Exit

 
• By Sue Sutter

The departure of Principal Deputy Commissioner Josh Sharfstein provides FDA an opportunity to 
take stock of its relationship with Congress and to 
re-evaluate its organizational structure.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet